Shop
Showing 689–704 of 1900 results
-
Article: Ibrutinib and idelalisib, the B-cell receptor antagonists available for use in daily clinical practice
€2.42 Add to cart -
Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders
€2.42 Add to cart -
Article: Identification of a novel staphylococcal binding partner for soluble von Willebrand factor-binding protein crucial for adhesion of Staphylococcus aureus to the vessel wall via von Willebrand factor
€2.42 Add to cart -
Article: Imbalance between supply and need of medical oncologists in Belgium
€2.42 Add to cart -
Article: Immune checkpoint blockade in lung cancer
€2.42 Add to cart -
Article: Immune checkpoint inhibition in triple negative breast cancer: targeting Achilles’ heel?
€2.42 Add to cart -
Article: Immune checkpoint inhibition in triple negative breast cancer: targeting Achilles’ heel?
€2.42 Add to cart -
Article: Immune-mediated early-onset neonatal thrombocytopenia: a double case presentation
€2.42 Add to cart -
Article: Immune-modulating antibodies in head and neck cancer: past, present, and future
€2.42 Add to cart -
Article: Immune-modulating antibodies in head and neck cancer: past, present, and future
€2.42 Add to cart -
Article: Immuno-oncology in transitional cell Carcinoma
€2.42 Add to cart -
Article: Immunomodulatory drugs: new developments
€2.42 Add to cart -
Article: Immunomodulatory drugs: new developments
€2.42 Add to cart -
Article: Immunotherapy for locally advanced unresectable non-small cell lung cancer
€2.42 Add to cart -
Article: Immunotherapy for locally advanced unresectable non-small cell lung cancer
€2.42 Add to cart -
Article: Immunotherapy Highlights
€2.42 Add to cart
